Tony Locantro, stock market commentator and investment manager at Alto Capital, speaks to Proactive Investors about the ASX biotech sector and its investment opportunities.
Biotech stocks may be the next best thing for small cap businesses to make money, according to Locantro, with ASX-listed companies boasting innovative stem cell technologies and trial-phase non-addictive painkillers.
“I just think it’s an exciting sector of the market and one to be involved in, at least to research,” says Locantro.
Meet Cardinal Resources Ltd and Legend Mining Ltd at our event, Melbourne , 16 July 2019. Register here »